144 0001856296 XXXXXXXX LIVE 0001635088 Roivant Sciences Ltd. 001-40782 7th Floor 50 Broadway London X0 SW1H 0DB 44 207 400 3347 Rakhi Kumar Chief Accounting Officer Common shares, $0.0000000341740141 par value per share ("Common Shares") E*TRADE FINANCIAL CORPORATION

3 EDISON DRIVE ALPHARETTA GA 30005

2671 29728.23 766811433 07/21/2023 Nasdaq Common Shares 07/20/2023 Restricted Stock Units granted under the Roivant Sciences Ltd. Amended and Restated 2015 Equity Incentive Plan Roivant Sciences Ltd. N 2671 07/20/2023 N/A N Rakhi Kumar

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

Common Shares 04/26/2023 87830 762283.86 Rakhi Kumar

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

Common Shares 04/27/2023 70969 603673 Rakhi Kumar

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

Common Shares 04/28/2023 71989 609829.07 Rakhi Kumar

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

Common Shares 05/01/2023 62219 533974.37 Rakhi Kumar

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

Common Shares 05/02/2023 15517 130685.55 Rakhi Kumar

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

Common Shares 05/23/2023 1557 14916.06 Rakhi Kumar

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

Common Shares 06/09/2023 43893 435857.49 Rakhi Kumar

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

Common Shares 06/22/2023 1357 13583.57 Rakhi Kumar

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

Common Shares 07/14/2023 535 6420 Rakhi Kumar

c/o Roivant Sciences Ltd. 7th Floor, 50 Broadway London X0 SW1H 0DB

Common Shares 07/18/2023 100 1200 The securities included in Table I represent a maximum number of shares that may be sold to cover the reporting person's tax obligations when restricted stock units belonging to the reporting person are settled. The securities reported in Table I do not represent discretionary trades by the reporting person, and will be sold, or were sold, as applicable, for the limited purpose of satisfying tax withholding obligations. The securities included in Table II sold on May 23, 2023 and June 22, 2023 represent shares sold to cover the reporting person's tax obligations when restricted stock units belonging to the reporting person were settled. Table II does not include shares that were "net settled" by the Issuer in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units previously granted to the reporting person. 07/21/2023 02/17/2022 /s/ Rakhi Kumar